JELD

JELD-WEN is in the middle of a severe, multi-year deterioration, and the numbers leave little room for a benign read. Revenue has fallen four straight years from a $4.54B peak in FY2022 to $3.21B in FY2025 (-14.9% YoY), a cumulative ~29% decline that reflects genuine end-market weakness, not just divestitures. Profitability has collapsed alongside it: FY2025 delivered a -$621M net loss (-$7.29 diluted EPS), a -$416M operating loss, and gross margin compressed to 16.0%. This is the second consecutive year of losses (FY2024 was -$189M), and the trend is accelerating downward, not stabilizing. Operating cash flow of -$4.86M against $120M of capex means the business burned free cash while still needing to invest to stay competitive.

The balance sheet is where 'avoid' becomes unavoidable. Stockholders' equity fell 85.1% to just $92.2M, retained earnings swung to a -$642M accumulated deficit, and liabilities/equity sits at 21.8x. ROE of -673% is a symptom of an equity base that has been almost entirely eroded by losses; another year like FY2025 mathematically wipes it out. With only $136M of cash and negative operating cash flow, the company's margin of safety against covenant or refinancing stress is thin. The market has already voted: at $1.44 and a $124M market cap, the stock is priced as a distressed, near-option-like claim on a turnaround that the filing gives no concrete evidence is underway.